^
Association details:
Biomarker:NSD1 mutation
Cancer:Solid Tumor
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
New
Source:
Title:

NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents

Excerpt:
...the pan-cancer cohort showed significantly increased sensitivity (p = 0.0198) to cisplatin for cell lines with NSD1 mutations (n = 18) compared to those with wild-type NSD1 (n = 798)...
DOI:
10.1186/s41199-019-0042-3